Product Images Meprobamate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Meprobamate NDC 51672-4148 by Taro Pharmaceuticals U.s.a., Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - meprobamate 01

Chemical Structure - meprobamate 01

PRINCIPAL DISPLAY PANEL - 200 mg Tablet Bottle Label - meprobamate 02

PRINCIPAL DISPLAY PANEL - 200 mg Tablet Bottle Label - meprobamate 02

The text is a medication label for EITRETID Meprobamate USP with a dosage of 200 mg. It instructs the user to refer to the package insert for dosage information and full prescribing details. The medication should be stored between 20°C - 25°C (68°F - 77°F) and has a child-resistant closure. The label was distributed by Taro Pharmaceuticals, USA, Inc. and is for prescription use only.*

PRINCIPAL DISPLAY PANEL - 400 mg Tablet Bottle Label - meprobamate 03

PRINCIPAL DISPLAY PANEL - 400 mg Tablet Bottle Label - meprobamate 03

NDC 51672-4148-1 is a medication called Meprobamate in tablet form with a strength of 400mg. The recommended dosage is mentioned in the package insert. The tablets should be stored in a container with a child-resistant closure at a temperature between 20°C - 25°C (68°F - 77°F). This medication is manufactured by Taro Pharmaceutical Industries Ltd. in Haifa Bay, Israel 26110, and distributed by their subsidiary Taro Pharmaceuticals U.S.A., Inc. located in Hawthorne, NY 10532. It is worth noting that TARO is a registered trademark of Taro Pharmaceuticals US A, Inc.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.